

Jo-1 antibodies are autoantibodies produced by the immune system against histidyl-tRNA synthetase (Jo-1), an enzyme essential for protein synthesis. Instead of protecting the body, these antibodies mistakenly attack its own tissues, leading to abnormal immune activity. Their presence in the blood is strongly linked to idiopathic inflammatory myopathies, especially polymyositis (causing muscle inflammation and weakness) and dermatomyositis (which involves muscle weakness along with characteristic skin rashes).
They are also closely associated with antisynthetase syndrome, a condition marked by muscle inflammation, interstitial lung disease, arthritis, Raynaud’s phenomenon, and mechanic’s hands (dry, cracked skin on the fingers). Detecting Jo-1 antibodies helps doctors confirm the diagnosis, monitor disease activity, and identify patients at higher risk of complications such as progressive lung involvement.
The Jo-1 antibody test is usually recommended when a patient presents with unexplained muscle weakness, fatigue, joint pain, difficulty swallowing, or skin rashes. It is also useful in assessing patients with interstitial lung disease, which can sometimes occur alongside these autoimmune disorders. Early detection of Jo-1 antibodies can help guide treatment decisions and improve disease management.
No special preparation is needed for getting the Jo-1 antibody test done. However, it is preferred that you share your clinical history, current medications, and supplement use with your doctor before giving the sample, as these may influence the results.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Do not self-medicate, and always consult a doctor to understand the test results correctly.
Please note: This is an outsourced test. The sample is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The Jo-1 antibody test detects autoantibodies against histidyl-tRNA synthetase, an enzyme essential for protein synthesis inside cells. The presence of these antibodies indicates an autoimmune reaction in which the immune system mistakenly attacks muscle and connective tissues.
Jo-1 antibodies are present in approximately 20–30% of patients with polymyositis or dermatomyositis and are considered highly specific for these conditions. Their presence is often associated with interstitial lung disease, arthritis, Raynaud’s phenomenon, and mechanic’s hands.
A positive result suggests a higher probability of inflammatory myopathies, especially when accompanied by respiratory symptoms or muscle weakness. However, a negative result does not completely rule out polymyositis or dermatomyositis, as not all patients with these conditions have Jo-1 antibodies. Results should always be interpreted alongside clinical symptoms, physical examination, imaging, and other laboratory investigations.
The Jo-1 antibody test is done:
- When symptoms such as muscle weakness, skin rashes, difficulty swallowing, or fatigue are present
- To investigate skin rashes along with muscle weakness (suggestive of dermatomyositis)
- To help diagnose idiopathic inflammatory myopathies
- To assess patients with suspected interstitial lung disease
- To differentiate from other muscle disorders
- To monitor disease progression and response to treatment in confirmed cases
- Often included in panels like the Myositis Profile, which evaluates multiple myositis-specific antibodies
- Clinical history is preferred.






















